Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1678820

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1678820

Germany Probiotic Food Supplement Market - 2025-2028

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3175
PDF & Excel (Multiple User License)
USD 3500
PDF & Excel (Enterprise License)
USD 6850

Add to Cart

The Germany probiotic food supplements market was US$ 135.46 million in 2020 and is expected to reach US$ 228.17 million in 2028 growing at a CAGR of 7.33% during the forecast period (2025-2028).

The Germany probiotic food supplement market is experiencing robust growth, driven by increasing consumer awareness of gut health, preventive healthcare trends and the rising popularity of plant-based diets. As one of Europe's largest economies with a strong focus on health and wellness, Germany represents a lucrative market for probiotic supplements.

Consumers are increasingly recognizing the link between gut microbiota and overall well-being, leading to a surge in demand for products that support digestion, immunity and mental health. According to EUSOSTAT, Germany leads the EU in preventive care spending, with €458 per inhabitant, reflecting the population's proactive approach to health management. This strong emphasis on preventive healthcare has significantly boosted the consumption of probiotic supplements as daily health aids rather than just therapeutic solutions.

Technological advancements are another key aspect of the market's evolution. The adoption of microencapsulation technologies ensures strain stability and extended shelf life, addressing critical challenges associated with probiotic viability. Furthermore, personalized nutrition is gaining traction, with companies offering DNA-based probiotic solutions tailored to individual gut profiles, reflecting a shift towards precision healthcare.

The Germany probiotic food supplement market is on a growth trajectory, supported by health-conscious consumer behavior, dietary shifts and technological innovations. With Germany's focus on preventive healthcare and functional nutrition, the market is well-positioned to witness continued growth, provided manufacturers can align their strategies with consumer preferences and regulatory requirements.

Drivers

Increasing Incidence of Gastrointestinal Disorders

The rising incidence of gastrointestinal (GI) disorders in Germany is a significant factor driving the growth of the probiotic food supplement market. According to a 2023 study, gastrointestinal infections in Germany account for 24.5 million outpatient visits annually, highlighting the widespread prevalence of digestive health issues.

Such a high burden of GI disorders underscores the growing need for effective solutions to restore gut health, manage symptoms and prevent recurring infections. Probiotic supplements play a crucial role in maintaining a healthy gut microbiome, which is essential for proper digestion and immunity. The increasing reliance on probiotics is also attributed to their ability to reduce the severity and duration of GI infections, alleviate symptoms of irritable bowel syndrome (IBS) and prevent antibiotic-associated diarrhea.

Moreover, surveillance of gastrointestinal infections in emergency departments has been strengthened to enable timely outbreak detection and disease trend monitoring, reflecting the government's proactive stance in addressing digestive health concerns. This enhanced surveillance allows healthcare providers to recommend probiotics as part of standardized care plans, further boosting market demand.

Additionally, the rise in outpatient visits linked to GI disorders has encouraged pharmaceutical companies and supplement manufacturers to develop targeted probiotic formulations catering to specific digestive issues. This growing incidence of GI disorders, combined with advancements in probiotic formulations and heightened consumer awareness of gut health, is expected to continue propelling the German probiotic food supplement market.

Rise of Plant-Based and Vegan Lifestyles

The rise of plant-based and vegan lifestyles in Germany is significantly boosting the probiotic food supplement market. With a growing focus on sustainable living, ethical consumption and health-conscious dietary choices, German consumers are increasingly adopting plant-based diets. This shift has created a strong demand for vegan and plant-based probiotic supplements, as traditional probiotic products often contain dairy-based ingredients.

Probiotics derived from plant sources not only cater to vegan preferences but also appeal to flexitarian consumers who are reducing their consumption of animal-based products for health and environmental reasons. According to the USDA, Germany has the highest rate of vegetarianism compared to its European neighbors, with the number of vegans reaching over 1.5 million people in 2022. Additionally, more than half of Germans describe themselves as flexitarians, opting for less animal-based food on their plates.

This growing demographic of vegans and flexitarians is driving demand for dairy-free, gluten-free and allergen-free probiotic supplements, which align with their dietary preferences. The rise in veganism is not only a lifestyle choice but also reflects concerns about sustainability, animal welfare and health, further emphasizing the need for plant-based alternatives in the supplement market. Thus, the growing adoption of plant-based and vegan lifestyles in Germany, supported by a large flexitarian population, is creating robust opportunities for vegan and plant-derived probiotic supplements.

Restraints

Limited Consumer Awareness of Probiotic Strains

Limited consumer awareness regarding specific probiotic strains and their targeted health benefits significantly restrains the growth of the Germany probiotic food supplement market. While general knowledge about probiotics is increasing, most consumers lack an understanding of how different strains serve distinct health purposes. For instance, Lactobacillus rhamnosus GG is known for supporting immune health and preventing antibiotic-associated diarrhea, while Bifidobacterium bifidum aids in alleviating irritable bowel syndrome (IBS) and improving digestion.

However, without sufficient awareness of these strain-specific benefits, consumers often perceive all probiotics as generic solutions, leading to confusion and hesitation in purchasing more specialized (and typically higher-priced) probiotic supplements. This lack of knowledge becomes particularly problematic when probiotic products are marketed with technical or scientific claims that are not easily understood by the general public.

For instance, premium probiotic brands like Biogena and Omniflora offer formulations containing specific strains tailored for particular health conditions, but these products may struggle to gain traction if consumers cannot differentiate them from standard probiotic offerings. Consequently, buyers may opt for more familiar or general wellness supplements, undermining the growth of niche probiotic segments. Addressing this challenge through educational initiatives, simplified labeling and healthcare provider engagement will be essential for unlocking the full potential of the probiotic food supplement market in Germany.

Segment Analysis

The Germany probiotic food supplement market is segmented based on ingredients, dosage, application, age and distribution channel.

Rising Incidences of Digestive Disorders

The demand for probiotic food supplements aimed at improving gastrointestinal health in Germany has been increasing, influenced by the prevalence of digestive disorders among the population. According to data from the Federal Statistical Office of Germany (Destatis), diseases of the digestive system accounted for a significant portion of health-related expenditures. Specifically, in 2023, the per capita expenditure on diseases of the digestive system was over €570 for individuals aged 15 and under, €400 for those aged 15 to 29, €550 for the 30 to 44 age group, €730 for those aged 45 to 64 and €730 for individuals aged 65 and above.

This substantial financial burden underscores the importance of preventive health measures, leading to a growing consumer interest in probiotics known for their beneficial effects on gut health. The increasing awareness of the role of gut microbiota in overall well-being has further propelled the adoption of probiotic supplements. Governmental health initiatives focusing on preventive care and the promotion of a balanced diet have also contributed to this trend, encouraging the population to consider probiotics as a viable option for maintaining digestive health.

Sustainability Analysis

The sustainability of Germany's probiotic food supplement market is influenced by several key factors, including consumer demand, regulatory frameworks and environmental considerations. Consumer interest in probiotics has been on the rise, driven by a growing awareness of gut health and overall well-being. This trend is evident in the increasing sales of dietary supplements, which saw a significant uptick during the COVID-19 pandemic as individuals sought to bolster their immune systems.

From a regulatory standpoint, Germany maintains stringent standards for food supplements, including probiotics. The Federal Office of Consumer Protection and Food Safety (BVL) oversees the market, ensuring that products meet safety and quality requirements. This robust regulatory environment fosters consumer confidence, which is essential for the market's long-term sustainability.

Environmental sustainability is also a pertinent aspect, as the production of probiotics involves the use of various natural resources. The German Environment Agency (UBA) advocates for sustainable manufacturing practices to minimize ecological footprints. Producers are encouraged to adopt energy-efficient processes and source raw materials responsibly, aligning with Germany's broader commitment to environmental protection.

Unmet Needs

Despite advancements in microbiome research, personalized probiotic supplements tailored to individual gut health profiles remain largely unavailable in the German market. Consumers increasingly seek customized health solutions that address specific conditions such as irritable bowel syndrome (IBS), mental health (gut-brain axis) and women's health.

While German consumers are aware of probiotics' general benefits, there is a knowledge gap regarding strain-specific advantages. Different probiotic strains offer distinct health benefits-for example, Lactobacillus rhamnosus GG for diarrhea prevention or Bifidobacterium longum for stress management.

Probiotics' sensitivity to temperature, moisture and light remains a critical unmet need, especially with the growing e-commerce segment in Germany. Many probiotic supplements lose potency when exposed to uncontrolled shipping conditions or improper storage at home, leading to ineffective products and consumer dissatisfaction.

There is a shortage of probiotic products specifically designed for children and elderly consumers in Germany. These demographics have distinct gut microbiome compositions and unique health requirements, such as immune support for children and bone health or cognitive support for older adults. While some brands offer generic formulations marketed as suitable for all ages, age-specific probiotics backed by clinical research are scarce.

While premium probiotic supplements with clinically validated strains are available, they are often priced beyond the reach of middle-income consumers. For example, clinically backed probiotics targeting specific conditions like gut-brain health or immune modulation can cost 30-50% more than general formulations. This price barrier limits the accessibility of high-quality probiotics to a broader population.

Competitive Landscape

The major players in the market include Orthomol pharmazeutische Vertriebs GmbH, SYMBIOPHARM GmbH, HLH BioPharma GmbH, Kaya Biotics GmbH, Dr. Wolz Zell GmbH, Queisser Pharma GmbH & Co. KG, Bioherba Reichenbach GmbH and Institut AllergoSan Pharmaceuticals Research & Sales GmbH. Additionally, major international and domestic brands, including AMWAY Germany, Culturelle (dsm-firmenich), Nestle Deutschland (Nestle S.A.), Biogaia and NATURTREU and others.

By Ingredient

  • Lactobacillus
  • Streptococcus
  • Bifidobacterium
  • Others

By Dosage

  • Tablet
  • Capsules
  • Liquid
  • Powder
  • Others
    • Chewables & Gummies
    • Soft Gels
    • Others

By Application

  • Gastrointestinal Health
    • Gut Microbiota/Microbiome Balance
    • Digestion
    • Constipation
    • Bloating
    • Diarrhea
    • Leaky Gut
    • Inflammation
    • Immune System
    • Others
  • Gluten sensitivity
  • Abdominal Pain
  • GERD/Helicobacter pylori
  • Antibiotic-Associated Diarrhea/Post-Antibiotic Treatment
  • Gut Flora/Gut Microbiome Restoration
  • Others
  • Vaginal Health
  • Urinary Tract Health
    • Kidney Stones
    • UTIs
    • Others
  • Oral Health
  • Anti/Healthy Ageing
  • Allergies/Asthma
  • Bone & Joint Health
    • Osteoarthritis
    • Osteoporosis/Low Mineral Bone Density
    • Inflammation
  • Brain/Mental Health
    • Sleep
    • Cognition
    • Mood
    • Depression
    • Focus
  • Cardiovascular Health
  • Circulation
  • Energy/Fatigue Reduction
  • Metabolic Syndrome/Blood Glucose
  • Liver Health
  • Energy
  • Immunity/Respiratory Infections
  • Nutrient Absorption
  • Skin-Hair-Nails
    • Atopic Dermatitis & Eczema
    • Acne
    • Rosacea
    • Hair Growth/Hair Loss
    • Skin Microbiome
    • Others
  • Sports
  • Women's Health
    • Fertility
    • Menopause
    • Pregnancy
    • Pcos
    • Vaginal Health & Health Vaginal Microbiome
    • Vaginal Infections (Bv/Vvc)
    • Pregnancy Outcomes
    • Others
  • Men's Health & Men's Fertility
  • Weight Management
  • Pediatric Health
    • Colic
    • Constipation
    • Regurgitation
    • Atopic Dermatitis
    • Others
  • Others

By Age

  • Infant
  • Children
  • Adults
  • Seniors

By Distribution Channels

  • Supermarkets/Hypermarkets
  • Pharmacies and Drug Stores
  • Convenience Stores
  • Online Retailers
  • Other Distribution Channels

Key Developments

  • TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife(R) Satylia(R) in Germany. The novel dietary supplement based on the next-generation probiotic Hafnia alvei HA4597 was launched in January 2023.

Why Purchase the Report?

  • To visualize the Germany probiotic food supplement market segmentation based on ingredient, dosage, application, age and distribution channel, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of Germany probiotic food supplement market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The Germany probiotic food supplement report would provide approximately 54 tables, 63 figures and 190 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: FB9232

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Ingredient
  • 3.2. Snippet by Dosage
  • 3.3. Snippet by Application
  • 3.4. Snippet by Age
  • 3.5. Snippet by Distribution Channel

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Incidence of Gastrointestinal Disorders
      • 4.1.1.2. Rise of Plant-Based and Vegan Lifestyles
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Consumer Awareness of Probiotic Strains
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. By Ingredient

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 6.1.2. Market Attractiveness Index, By Ingredient
  • 6.2. Lactobacillus*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Streptococcus
  • 6.4. Bifidobacterium
  • 6.5. Others

7. By Dosage

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 7.1.2. Market Attractiveness Index, By Dosage
  • 7.2. Tablet*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Capsules
  • 7.4. Liquid
  • 7.5. Powder
  • 7.6. Others
    • 7.6.1. Chewables & Gummies
    • 7.6.2. Soft Gels
    • 7.6.3. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Gastrointestinal Health*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Gut Microbiota/Microbiome Balance
    • 8.2.4. Digestion
    • 8.2.5. Constipation
    • 8.2.6. Bloating
    • 8.2.7. Diarrhea
    • 8.2.8. Leaky Gut
    • 8.2.9. Inflammation
    • 8.2.10. Immune System
    • 8.2.11. Others
      • 8.2.11.1. Gluten sensitivity
      • 8.2.11.2. Abdominal Pain
      • 8.2.11.3. GERD/Helicobacter pylori
      • 8.2.11.4. Antibiotic-Associated Diarrhea/Post-Antibiotic Treatment
      • 8.2.11.5. Gut Flora/Gut Microbiome Restoration
      • 8.2.11.6. Others
  • 8.3. Vaginal Health
  • 8.4. Urinary Tract Health
    • 8.4.1. Kidney Stones
    • 8.4.2. UTIs
    • 8.4.3. Others
  • 8.5. Oral Health
  • 8.6. Anti/Healthy Ageing
  • 8.7. Allergies/Asthma
  • 8.8. Bone & Joint Health
    • 8.8.1. Osteoarthritis
    • 8.8.2. Osteoporosis/Low Mineral Bone Density
    • 8.8.3. Inflammation
  • 8.9. Brain/Mental Health
    • 8.9.1. Sleep
    • 8.9.2. Cognition
    • 8.9.3. Mood
    • 8.9.4. Depression
    • 8.9.5. Focus
  • 8.10. Cardiovascular Health
  • 8.11. Circulation
  • 8.12. Energy/Fatigue Reduction
  • 8.13. Metabolic Syndrome/Blood Glucose
  • 8.14. Liver Health
  • 8.15. Energy
  • 8.16. Immunity/Respiratory Infections
  • 8.17. Nutrient Absorption
  • 8.18. Skin-Hair-Nails
    • 8.18.1. Atopic Dermatitis & Eczema
    • 8.18.2. Acne
    • 8.18.3. Rosacea
    • 8.18.4. Hair Growth/Hair Loss
    • 8.18.5. Skin Microbiome
    • 8.18.6. Others
  • 8.19. Sports
  • 8.20. Women's Health
    • 8.20.1. Fertility
    • 8.20.2. Menopause
    • 8.20.3. Pregnancy
    • 8.20.4. Pcos
    • 8.20.5. Vaginal Health & Health Vaginal Microbiome
    • 8.20.6. Vaginal Infections (Bv/Vvc)
    • 8.20.7. Pregnancy Outcomes
    • 8.20.8. Others
  • 8.21. Men's Health & Men's Fertility
  • 8.22. Weight Management
  • 8.23. Pediatric Health
    • 8.23.1. Colic
    • 8.23.2. Constipation
    • 8.23.3. Regurgitation
    • 8.23.4. Atopic Dermatitis
    • 8.23.5. Others
  • 8.24. Others

9. By Age

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 9.1.2. Market Attractiveness Index, By Age
  • 9.2. Infant*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Children
  • 9.4. Adults
  • 9.5. Seniors

10. By Distribution Channel

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.1.2. Market Attractiveness Index, By Distribution Channel
  • 10.2. Supermarkets/Hypermarkets*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Pharmacies and Drug Stores
  • 10.4. Convenience Stores
  • 10.5. Online Retailers
  • 10.6. Other Distribution Channels

11. Sustainability Analysis

  • 11.1. Environmental Analysis
  • 11.2. Economic Analysis
  • 11.3. Governance Analysis

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Orthomol pharmazeutische Vertriebs GmbH*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. SYMBIOPHARM GmbH
  • 13.3. HLH BioPharma GmbH
  • 13.4. Kaya Biotics GmbH
  • 13.5. Dr. Wolz Zell GmbH
  • 13.6. Queisser Pharma GmbH & Co. KG
  • 13.7. Bioherba Reichenbach GmbH
  • 13.8. Institut AllergoSan Pharmaceuticals Research & Sales GmbH
  • 13.9. AMWAY Germany
  • 13.10. Culturelle (dsm-firmenich)
  • 13.11. Nestle Deutschland (Nestle S.A.)
  • 13.12. Biogaia
  • 13.13. NATURTREU

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!